Email updates

Keep up to date with the latest news and content from BMC Pharmacology and BioMed Central.

Open Access Highly Accessed Research article

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa

Hideyuki Sato1, Ruediger Nave2, Takashi Nonaka1, Nishibe Yoshihisa1, Nagano Atsuhiro1, Tsutomu Mochizuki1, Shigehiro Takahama1, Shiro Kondo1 and Mark Wingertzahn3*

Author Affiliations

1 Teijin Institute for Biomedical Research, TEIJIN Pharma Limited, 4-3-2 Asahigaoka, Hino, Tokyo 191-8512, Japan

2 ALTANA Pharma AG, Byk-Gulden-Str. 2, 78467 Konstanz, Germany

3 ALTANA Pharma, 220 Park Avenue, Florham Park, NJ 07932, USA

For all author emails, please log on.

BMC Pharmacology 2007, 7:7  doi:10.1186/1471-2210-7-7

Published: 6 June 2007



The nasal tissue uptake and metabolism of ciclesonide, a new-generation corticosteroid under investigation for treatment of allergic rhinitis, to its active metabolite, desisobutyryl-ciclesonide (des-CIC), was evaluated when administered to rabbits in a hypotonic versus an isotonic ciclesonide suspension. Nasal mucosa extracts from normal Japanese white rabbits were evaluated by high-performance liquid chromatography with tandem mass spectrometry detection after a single 143-μg dose of ciclesonide. Retention and formation of fatty acid conjugates of des-CIC were also measured in nasal mucosa extracts postadministration of a hypotonic ciclesonide suspension (143-μg single dose).


Versus an isotonic suspension, the hypotonic suspension achieved higher concentrations of des-CIC (5.6-fold, 11.4-fold, and 13.4-fold; p < 0.05 for all) and ciclesonide (25.3-fold, 34.2-fold [p = not significant], and 16-fold [p < 0.05]) at 30, 120, and 240 min postadministration. Additionally, when administered via a hypotonic suspension, des-CIC was retained up to 24 h postadministration (45.46 pmol/g tissue). Highest concentration of major fatty acid ester conjugate, des-CIC-oleate, was detected in nasal mucosa at 8 h postadministration.


These data suggest that a hypotonic ciclesonide suspension provides higher intracellular concentrations of des-CIC up to 24 h, thereby providing a rationale for investigation of ciclesonide as a convenient once-daily nasal spray for treatment of allergic rhinitis.